Patent Assignment
Reel/Frame 056775/0375
Change of Address
Recorded: 2021-03-22
Pages: 14
Assignor
RHIZEN PHARMACEUTICALS SA
Executed: 2020-12-08
Assignee
RHIZEN PHARMACEUTICALS SA
STEINENTORSTRASSE 23, BASEL, 4051, SWITZERLAND
Covered Properties
(72)
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Application:
17/247,806 →
Publication:
US US20210269446A1
Novel Selective PI3K Delta Inhibitors
Application:
61/691,586 →
Novel Selective PI3K Delta Inhibitors
Novel Kinase Modulators
Application:
61/364,661 →
Novel Kinase Modulators
Novel Modulators of Calcium Release- Activated Calcium Channel
Application:
61/265,540 →
Novel Modulators of Calcium Release-Activated Calcium Channel and Methods for Treatment of Non-Small Cell Lung Cancer
Application:
16/168,499 →
Publication:
US US20190248791A1
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Application:
14/534,909 →
Publication:
US US20150133449A1
Novel Bicyclic Compounds as Modulators of Gpr-119
Application:
61/543,152 →
Novel Compounds as Modulators of Gpr-119
Application:
61/543,157 →
Novel Compounds as Modulators of Gpr-119
Application:
15/674,376 →
Publication:
US US20170342089A1
Intermediates Useful in the Synthesis of Compounds as Modulators of Protein Kinases
Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Novel Selective Inhibitors of PI3K Delta Protein Kinases
Application:
61/691,561 →
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of C-Met Protein Kinases
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a P13 Delta or Dual P13 Delta-Gamma Kinase Inhibitor
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
PI3K Protein Kinase Inhibitors
Novel Glutaminase Inhibitors
Application:
16/825,755 →
Publication:
US US20210032236A1
Inhibitors of Glutaminase
Application:
14/769,365 →
Publication:
US US20160297761A1
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Application:
16/212,447 →
Publication:
US US20190202836A1
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Application:
16/810,219 →
Publication:
US US20200199133A1
Method of Treatment and Compositions Comprising a Dual P13K Delta-Gamma Kinase Inhibitor and a Corticosteroid
Application:
16/999,825 →
Publication:
US US20210030757A1
Crac Channel Modulators for Treating Esophageal Cancer
Application:
16/756,077 →
Publication:
US US20200237743A1
Calcium Release-Activated Calcium Channel Modulators for Treating Hematological and Solid Cancers
Application:
16/759,629 →
Publication:
US US20200281918A1
Composition and Method for Treating Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Application:
16/762,870 →
Publication:
US US20200289520A1
Compositions Comprising a Crac Inhibitor and a Corticosteroid and Methods of Use Thereof
Application:
17/250,864 →
Publication:
US US20220040162A1
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Novel Selective PI3K Delta Inhibitors
Improved Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Novel Selective PI3K Delta Inhibitors
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Novel Selective PI3K Delta Inhibitors
Forms of a PI3K Delta Selective Inhibitor for Use in Pharmaceutical Formulations
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Novel Modulators of Calcium Release-Activated Calcium Channel and Methods for Treatment of Non-Small Cell Lung Cancer
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Novel Compounds as Modulators of Protein Kinases
Patent:
10,220,035 →
Application:
14/750,953 →
Novel Modulators of Calcium Release-Activated Calcium Channel
Substituted Chromenones as Modulators of Protein Kinases
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
2,3-Disubstituted Chromen-4-One Compounds as Modulators of Protein Kinases
Novel Kinase Modulators
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Novel Glutaminase Inhibitors
Novel Modulators of Calcium Release-Activated Calcium Channel
Method of Treatment and Compositions Comprising a Dual PI3K Delta-Gamma Kinase Inhibitor and a Corticosteroid
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5- Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
4H-Chromen-4-One Compounds as Modulators of Protein Kinases
Novel Immunomodulator and Anti-Inflammatory Compounds
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted -3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of Protein Kinases
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Modulators of Calcium Release-Activated Calcium Channel and Methods for Treatment of Non-Small Cell Lung Cancer
Substituted Chromenes as Kinase Modulators
Bicyclic Compounds as Modulators of Gpr-119
Novel Process for Preparation of Optically Pure and Optionally Substituted 2-(1-Hydroxy-Alkyl)-Chromen-4-One Derivatives and Their Use in Preparing Pharmaceuticals
Novel Kinase Modulators
Selective Dual Inhibitors of PI3 Delta and Gamma Protein Kinases
Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Novel Immunomodulator and Anti-Inflammatory Compounds
Novel Modulators of Calcium Release-Activated Calcium Channel
Novel Compounds as Modulators of Protein Kinases
Novel Compounds as Modulators of Gpr-119
Novel Glutaminase Inhibitors
Dual Selective PI3 Delta and Gamma Kinase Inhibitors
Novel 3,5-Disubstituted-3H-Imidazo[4,5-B]Pyridine and 3,5-Disubstituted-3H-[1,2,3]Triazolo[4,5-B] Pyridine Compounds as Modulators of C-Met Protein Kinases
Novel Modulators of Calcium Release-Activated Calcium Channel
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 7, 2014
From: NAGARATHNAM, DHANAPALAN; VAKKALANKA, SWAROOP KUMAR V.S.; VISWANADHA, SRIKANT; MERIKAPUDI, GAYATRI S.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 032615/0722 →
Assignment of Assignor's Interest
Oct 19, 2015
From: BHAVAR, PRASHANT K; VAKKALANKA, SWAROOP K; VISWANADHA, SRIKANT; MERIKAPUDI, GAYATRI S
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 036824/0057 →
Assignment of Assignor's Interest
Feb 16, 2016
From: BHAVAR, PRASHANT K; VAKKALANKA, SWAROOP K; BABU, GOVINDARAJULU
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 037745/0334 →
Assignment of Assignor's Interest
Nov 3, 2020
From: VISWANADHA, SRIKANT; VAKKALANKA, SWAROOP KUMAR VENKATA SATYA
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 054259/0278 →
Change of Address
Oct 6, 2021
From: RHIZEN PHARMACEUTICALS AG
To: RHIZEN PHARMACEUTICALS AG
Reel/Frame 057836/0286 →
Assignment of Assignor's Interest
Nov 13, 2023
From: MUTHUPPALANIAPPAN, MEYYAPPAN; VISWANADHA, SRIKANT; BABU, GOVINDARAJULU
To: INCOZEN THERAPEUTICS PVT. LTD.
Reel/Frame 065546/0453 →
Assignment of Assignor's Interest
Nov 13, 2023
From: VAKKALANKA, SWAROOP KUMAR V.S.
To: RHIZEN PHARMACEUTICALS SA
Reel/Frame 065546/0506 →
Assignment of Assignor's Interest
Nov 13, 2023
From: INCOZEN THERAPEUTICS PVT. LTD.
To: RHIZEN PHARMACEUTICALS AG
Reel/Frame 065546/0582 →